Cargando…
Brief Report: Virologic Impact of the Dolutegravir Transition: Prospective Results From the Multinational African Cohort Study
The real-world impact on viral suppression of switching from non–dolutegravir-based therapy to tenofovir/lamivudine/dolutegravir (TLD) is not thoroughly characterized in Africa. We described the virologic consequences of switching regimens in the African Cohort Study (AFRICOS), an observational coho...
Autores principales: | Esber, Allahna, Dear, Nicole, Shah, Neha, Kibuuka, Hannah, Maswai, Jonah, Owuoth, John, Singoei, Valentine, Bahemana, Emmanuel, Iroezindu, Michael, Crowell, Trevor A., Polyak, Christina S., Cavanaugh, Joseph S., Ake, Julie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561234/ https://www.ncbi.nlm.nih.gov/pubmed/35980350 http://dx.doi.org/10.1097/QAI.0000000000003065 |
Ejemplares similares
-
Weight gain during the dolutegravir transition in the African Cohort Study
por: Esber, Allahna L., et al.
Publicado: (2022) -
Routine HIV clinic visit adherence in the African Cohort Study
por: Dear, Nicole, et al.
Publicado: (2022) -
1479. Analysis of Depression in People Living with Human Immunodeficiency Virus (HIV) During the Coronavirus Disease 2019 Pandemic in 4 African Countries
por: Adjei, Paul, et al.
Publicado: (2023) -
Prevalence and risk factors associated with HIV and syphilis co-infection in the African Cohort Study: a cross-sectional study
por: Gilbert, Laura, et al.
Publicado: (2021) -
2324. COVID-19 Knowledge, Attitudes, and Practices Among People Living with HIV in Sub-Saharan Africa
por: Cebula, Brennan R, et al.
Publicado: (2023)